Skip to content

Nebraska NHSN Antibiotic Use and Resistance Reporting

Nebraska NHSN Antibiotic Use and Resistance Reporting: Implementation Progress and Updates The CDC’s National Healthcare Safety Network Antimicrobial Use and…

arrow_forward
AS Newsletter 2026 07 28

The Antimicrobial Advocate, Volume 3, Issue 7

Highlights from this issue: 2026 Nebraska Infectious Disease Conference CDC Core Elements of Outpatient AS CLSI M100 free access Education…

arrow_forward
Antimicrobial Advocate V3 I5 6 MayJune2026

The Antimicrobial Advocate, Volume 3, Issue 5-6

Highlights from this issue: Tebipenem FDA approval Guidance for AS Program Leaders Review of C. auris Cefazolin vs. Antistaphylococcal Penicillins…

arrow_forward

The Antimicrobial Advocate, Volume 3, Issue 4

Highlights from this issue: Surviving Sepsis Guidelines 2026 NHSN AUR Module Updates SHEA Learning: Frontline LTC Staff The Antimicrobial Advocate…

arrow_forward

The Antimicrobial Advocate, Volume 3 Issue 3

Highlights from this issue: Microbiology Nudge Survey Updated Appendicitis Guidelines SHEA Learning: Frontline LTC Staff The Antimicrobial Advocate March 2026

arrow_forward

The Antimicrobial Advocate, Volume 3, Issue 2

Highlights from this Issue: Prescribing Perspective: NE Outpatient Antibiotic Use Trends Long-Term Care Trends in Antibiotic Use and Stewardship Literature…

arrow_forward

The Antimicrobial Advocate, Volume 3, Issue 1

Highlights from this issue: NE ASAP 2025 Year in Review In the Literature: Antimicrobial Use During the Last Month of…

arrow_forward

The Antimicrobial Advocate, Volume 2, Issue 12

Highlights from this issue: Overview of cefdinir Cefdinir usage data in Nebraska A study on cefdinir vs cephalexin for UTI’s…

arrow_forward

The Antimicrobial Advocate, Volume 2, Issue 11

In this issue you’ll find: NE ASAP LTC Toolkit Antibiotic Awareness Week Beta lactam vs non-Beta lactam surgical prophylaxis The…

arrow_forward

The Antimicrobial Advocate, Volume 2, Issue 10

Highlights from this month’s issue: The DOTS Trial – Dalbavancin for Treatment of Staphylococcus aureus Bacteremia PALTmed COVID-19 Vaccine Statement…

arrow_forward

The Antimicrobial Advocate, Volume 2, Issue 9

In this issue you’ll find: Recent updates in Asymptomatic Bacteriuria (ASB) literature VA study of outpatient ASB treatment Management of…

arrow_forward

The Antimicrobial Advocate, Volume 2, Issue 8

Highlights from this issue include: Review of Oral Cephalosporins for common outpatient infections, Hitting pause on PCR: Rethinking UTI testing…

arrow_forward

The Antimicrobial Advocate, Volume 2, Issue 7

Highlights from this issue include: IDSA Complicated UTI Guidelines, Bicillin L-A Recall, APIC Safe Injection Practices http://asap.nebraskamed.com/wp-content/uploads/sites/3/2025/07/The-Antimicrobial-Advocate-July-2025.pdf    

arrow_forward
Scroll To Top expand_less

Please provide your details below to reach out to our ASAP team on any questions about Antimicrobial Stewardship.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Address*
Name*